Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Daniel Aird
Introduction
Daniel Aird is a notable inventor based in Reading, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His work focuses on the development of innovative combinations of drugs that target specific pathways in cancer cells.
Latest Patents
Daniel Aird holds a patent for a combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors. This patent outlines methods of treating cancer by administering a therapeutically effective amount of these compounds. The innovative approach aims to enhance the efficacy of cancer treatments by targeting multiple mechanisms involved in tumor growth.
Career Highlights
Throughout his career, Daniel has demonstrated a commitment to advancing cancer therapies. His work at Eisai R&D Management Co., Ltd. has positioned him as a key player in the pharmaceutical industry. With a focus on research and development, he continues to explore new avenues for effective cancer treatment.
Collaborations
Daniel Aird collaborates with talented professionals in his field, including Laura Corson and Ping Zhu. These partnerships enhance the research efforts and contribute to the development of groundbreaking therapies.
Conclusion
Daniel Aird's innovative work in the pharmaceutical industry exemplifies the impact of targeted drug combinations in cancer treatment. His contributions are paving the way for more effective therapies that can improve patient outcomes.